• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Advertisement
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Science & Tech

Oxford vaccine- AZD1222

January 1, 2021
in Science & Tech, Society
Reading Time: 2 mins read
0
Oxford vaccine- AZD1222
186
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook

In news

The United Kingdom approved the Oxford vaccine recently

About Oxford vaccine

  • The Oxford-AstraZeneca vaccine has been approved for use in the UK
  • AZD1222, also known as ChAdOx1 nCoV-19, is a COVID-19 vaccine developed by Oxford University and AstraZeneca given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1.
  • The AZD1222 vaccine is a replication-deficient simian adenovirus vector, containing the full‐length codon‐optimized coding sequence of SARS-CoV-2 spike protein along with a tissue plasminogen activator (tPA) leader sequence.
  • The researchers used the SARS-CoV-2 genome that had been sequenced in Wuhan
  • Unlike the Pfizer and Moderna vaccines, the ‘Oxford vaccine’ doesn’t require sub-zero refrigeration and is reportedly more conducive to be distributed in India.
  • AstraZeneca aims to supply millions of doses in the first quarter as part of an agreement with the government to supply up to 100 million doses in total.
  • Both AstraZeneca and Pfizer have been approved in the U.K. and the U.S. respectively after they publicised data from their ongoing phase-3 trials.
  • The Pfizer-BioNTech jab’s trials showed two full doses were 95% effective at preventing infection, while the Oxford-AstraZeneca vaccine showed 62% effectiveness – although even in cases where people were infected, there were no cases of serious illness needing hospital treatment.
  • Oxford-AstraZeneca vaccine’s trials also showed that when people were given a half dose then a full dose, effectiveness hit 90%.
  • It uses a chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein

Significance of approval for India

  • This is significant for India, as the Pune-based Serum Institute of India (SII) has tied up with AstraZeneca to deploy the vaccine in the country.
  • After the recent approval, the country’s drug regulator has said that it reviewed an application by the SII for ‘emergency use authorization (EUA).
Source: The Hindu & BBC
Tags: Prelims

Related Posts

Multi-beam E-band product Giga Mesh

Multi-beam E-band product Giga Mesh

March 30, 2021
Apatani tribe

Apatani tribe

March 30, 2021
Sanskritisation

Sanskritisation

March 30, 2021
Vaccine wastage

Vaccine wastage

March 29, 2021
Rohingya Muslims

Rohingya Muslims

March 29, 2021
Beauty Quarks

Beauty Quarks

March 27, 2021
Helium : Emerging Crisis for India

Helium : Emerging Crisis for India

March 27, 2021
SC Guidelines on Handling Cases of Sexual Crimes by the Judiciary

SC Guidelines on Handling Cases of Sexual Crimes by the Judiciary

March 26, 2021
100+ Curriculum based Comic books launched

100+ Curriculum based Comic books launched

March 26, 2021
World Tuberculosis Day

World Tuberculosis Day

March 26, 2021
Please login to join discussion
March 2021
MTWTFSS
1234567
891011121314
15161718192021
22232425262728
293031 
« Feb    

Browse by Category

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Uncategorized

Browse by Tags

AIR Down to Earth GS-1 GS-2 GS-3 GS-4 India & the world Kurukshetra Mains news News Paper PIB Prelims PRS India RSTV Science Reporter Survey Yojana
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Uncategorized

Browse by Tag

AIR Down to Earth GS-1 GS-2 GS-3 GS-4 India & the world Kurukshetra Mains news News Paper PIB Prelims PRS India RSTV Science Reporter Survey Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In